Allogenic Islet Cell Transplantation

Clinical trial NCT00160732 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00160732
Sponsor: University of Chicago
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2003-10-01
Primary completion: 2030-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.